Money Is Flowing Into Biopharma But Funders Are Investing Selectively
Financial Turnaround Remains Elusive, 2024 Uncertain
Venture capital and public market fundraising have grown increasingly difficult since 2021, but while there are glimmers of hope, the rules for who can raise venture cash or launch an IPO have changed.
